Eric Gordon MD

Eric Gordon is the founder of Gordon Medical Associates, an internationally recognized treatment center for difficult to diagnosis and treat conditions, including Lyme, Chronic Fatigue Syndrome, Fibromyalgia, Autism, Multiple Chemical Sensitivity, and other illness that is often overlooked or left untreated.


Videos from the Millions Missing Rally

Eric Gordon at Millions Missing rally

Eric Gordon speaking at the Millions Missing ME/CFS rally on September 27

You can see videos of the speakers at the San Francisco Millions Missing rally on Facebook at the Chronic Fatigue Syndrome Research Center at Stanford University page.

Following patient speakers, you can hear Eric Gordon speak (video) beginning at about 31.35  minutes in.

Ron Davis follows talking about how to get more research happening.

Millions Missing San Francisco video on Facebook

More speakers (video)


Images from the Millions Missing Rally for ME/CFS


Press Democrat: Santa Rosa doctor’s study offers new insight into chronic fatigue syndrome

THE PRESS DEMOCRAT | September 21, 2016

Eric Gordon MDA new study initiated by (Eric) Gordon and including Harrison as one of the subjects could provide that breakthrough.

The study, published last month, detected a “chemical signature” in the blood of chronic fatigue syndrome patients, establishing for the first time that chronic fatigue syndrome is an “objective metabolic disorder,” said co-author Dr. Robert Naviaux, the UC San Diego researcher who identified the blood chemical anomalies associated with the condition.

Gordon is a co-author of the study, and most of the patients in the study came from his practice.

Read PD Article

Read Full Study Paper


Gordon Medical Research Center is organizing a new community sponsored research study to investigate how individual metabolomic data can be used to evaluate CFS/ME.

GMRC logo paddedThis will be the third study organized by GMRC researching how comprehensive metabolomic analysis can be used to evaluate CFS/ME. This study follows our first study, recently published in the Proceedings of the National Academy of Science, which demonstrated there is a clear metabolomic profile in patients with CFS/ME; and our second North American based CFS/ME study, which has finished enrolling patients and will be completed soon. (see more about Metabolomics research)

Evidence that CFS truly does deserve all three elements of its name has accumulated over the years but a definitive diagnostic test has remained elusive. Until, perhaps, now. For in this week’s Proceedings of the National Academy of Sciences Robert Naviaux of the University of California, San Diego, and his colleagues published evidence that the metabolisms of those diagnosed with CFS are all changing in the same way. Their data suggest it is this cellular response to CFS-triggering traumas, and not the way the response is set in motion, which should define the illness. They also show that this response produces a chemical signal that might be used for diagnosis.

The Economist

This third study will be the first to look at how individual as opposed to population based metabolomics data can be used to evaluate CFS/ME. GMRC’s third CFS/ME research study will be a community-sponsored investigation. The CFS/ME community is a highly motivated group and we will need their support to accomplish our goal of understanding how personal metabolomic data can be used to evaluate CFS/ME.

Members of the CFS/ME community and their advocates can contribute to the success of the study in three main ways:

  1. They can participate in the study by volunteering a blood sample. – PARTICIPATE
  2. They can recruit a person without a diagnosis of CFS/ME to donate a blood sample that will serve as a comparison sample.
  3. Members of the community can make a tax-deductible donation to fund the study. – DONATE

All donations are welcome, and donations to this third metabolomic study will go to sample collection, metabolomic data generation, and development of CFS/ME-specific analysis software.

For a donation of $1500 or more, individuals will receive a personal metabolomic report that will show them how their personal metabolomic profile compares to a healthy population and the overall CFS population. Included in the >500 metabolites in this report will be analysis of sphingomyelin metabolites which were shown to be of interest to the CFS/ME community in our first study. This is the ONLY metabolomic report currently capable of providing data on this critical class of molecules.


We look forwarded to working with the CFS/ME patient community and their supporters to make this unique community-sponsored research study a success.



New Study Published: Metabolic features of chronic fatigue syndrome

Robert NaviauxMetabolic features of chronic fatigue syndrome. Naviaux RK, Naviaux JC, Li K, Bright AT, Alaynick WA, Wang L, Baxter A, Nathan N, Anderson W, Gordon E. Proc Natl Acad Sci U S A. 2016 Aug 29.

Download a PDF copy – Metabolic features of chronic fatigue syndrome

The Metabolomics study done in collaboration with Robert Naviaux of the Naviaux Lab and Gordon Medical Associates is now available!

Here we report a metabolomics study of Chronic Fatigue Syndrome (CFS) in 45 CFS patients and 39 controls. Our data show that despite the heterogeneity of factors leading to CFS, the cellular metabolic response in patients was homogeneous, statistically robust, and chemically similar to the evolutionarily conserved persistence response to environmental stress known as dauer.

Read full paper…

Some people still argue that CFS is not a real illness but all in the mind. Does your discovery of a chemical signature help shatter this myth?

Yes. The chemical signature that we discovered is evidence that CFS is an objective metabolic disorder that affects mitochondrial energy metabolism, immune function, GI function, the microbiome, the autonomic nervous system, neuroendocrine, and other brain functions. These 7 systems are all connected in a network that is in constant communication. While it is true that you cannot change one of these 7 systems without producing compensatory changes in the others, it is the language of chemistry and metabolism that interconnects them all.

Metabolomics Q&A for CFS v6 

Support further research at the Gordon Medical Research Center


Gordon Medical Research Center Now Funding Replication Study on CFIDS/ME Findings

Eric Gordon MDBy Eric Gordon, MD

The collaboration of an innovative medical practice with a university research center has been my lifelong dream.  Combining forces with Dr. Robert Naviaux and his research into metabolomics, mitochondrial function, and chronic inflammatory disease is now bringing this dream to life.

The opening of the Gordon Medical Research Center is a critical element in developing funding for the research into the complex illnesses we focus on. Your donation will make possible further research into metabolomics and mitochondrial function and their impact on health and illness. Illnesses potentially caused by mitochondrial dysfunction will ultimately affect over 50% of the people born today. These diseases include autoimmune diseases, autism, Myalgic Encephalopathy/Chronic Fatigue Syndrome  (ME/CFS), Post-Traumatic Stress Disorder (PTSD), Gulf War Illness,  diabetes, heart disease, certain mental health disorders, and cancer.

Eric Gordon, MD
Founder, Gordon Medical Associates
Science in Service of Humanity
Gordon Medical Research Center
Funding Research For Poorly Defined and Undiagnosed Chronic Illness

Dr. Robert Naviaux and I have submitted for publication a study, now under peer review and expected to be published in the fall of 2016, [Read more…]


Patient Powered Research into Lyme Disease

We recommend that you look into the research being done by through MyLymeData. Being able to collect information from thousands of Lyme patients has the potential to open up new avenues of Lyme disease research. Watch the video, and then go to the website to learn more, and sign up to participate!

Imagine a world where people with Lyme disease are diagnosed and treated correctly and go back to living their lives.

Add your Lyme data to MyLymeData
to help find a cure for Lyme disease.

MyLymeData is a patient-powered research project. It was conceived by patients, is run by patients, and addresses the issues that patients care about. It lets Lyme disease patients learn from each other and provides data that can help drive research to improve their lives.


Did you ever think it would be possible to significantly decrease or even cure persistent pain without strong drugs or injections?



Change the Brain; Relieve the Pain; Transform the Person

Dr. Michael Moskowitz MD has developed a strategy called  “Neuroplastic Transformation” training the brain to change itself back to the healthy state that existed before persistent pain developed.  Neuroplastix is dedicated to curing the disease of persistent pain in all people who suffer by unifying brain and body as the focus of treatment.

The educational programs establish a new paradigm in pain care, bringing advances in neuroscience to anyone affected by persistent pain, including patients, their families and providers. This is accomplished via conferences, interactive materials, scientific publications and professional training, providing a method to transform the clinical treatment of pain.

For more information on Dr. Moskowitz go to

Join Dr. Moskowitz  in person and via webinar Wednesday May 11th 6:30 – 8:30 pm MDT and celebrate International Awareness Day for ME/CFS, FM and MCS.

To register go to:


The Future of Medicine and Health

The Cutting Edge of Health and Wellness Today
Friday, June 26, at 2 PM Pacific

The Future of Medicine and Health

I am delighted to be joined today by my friend and colleague Dr. Eric Gordon, founder of our clinic, Gordon Medical Associates. We will launch into a discussion of where we feel the future of medical care is going from a variety of perspectives. One particularly exciting new development is our work with Dr. Naviaux’s concept of the Cell Danger Response and how that work has the potential to change the way medicine is practiced.


[Read more…]


Fluoride Danger to Children

SUNDAY APRIL 19, 2015:

William J. Hirzy, PhD will speak on fluoride danger to children.

Dr. Bill Hirzy (2015). Photo courtesy of Ellen Connett.

Dr. Bill Hirzy (2015). Photo courtesy of Ellen HIrzy.

Dr. Bill Hirzy, longtime top scientist for EPA Toxics Risk Assessment, will discuss the risks of fluoridated water to our children, followed by a Q & A session during which you can get answers to your questions direct from Dr. Hirzy.

Board Certified local physician Dr. April Hurley will be on hand in the lobby, before and after the presentation, to answer questions about fluoridated water from a medical viewpoint. You are invited to bring your friends and your questions.

[Read more…]